| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Ab182769-100μg |
100μg |
现货  |
| |
| Ab182769-1mg |
1mg |
现货 |
| |
| Ab182769-5mg |
5mg |
现货 |
| |
| Ab182769-10mg |
10mg |
期货 |
|
| 产品名称 | Letolizumab (anti-TNFSF5) |
|---|---|
| 别名 | 来利珠单抗 | 来妥珠单抗（抗肿瘤坏死因子FF5） |
| 英文别名 | CD154 antibody | CD40 antigen ligand antibody | CD40L antibody | CD40LG antibody | Gp39 antibody | HIGM1 antibody | Hyper IgM syndrome antibody | IGM antibody | IMD3 antibody | Ly62 antibody | T B cell activating molecule antibody | TBAM antibody | TNF re |
| 规格或纯度 | 无载体, 重组, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
| 宿主种属 | 人(Human) |
| 特异性 | CD40LG |
| 种属反应性 | 人(Human) |
| 偶联 | Unconjugated |
| 克隆类型 | 重组抗体 |
|---|---|
| Format | VHH-hFc |
| 亚型 | VHH-Fc |
| SDS-PAGE | 26.3 kDa (Light Chain) & 53.0 kDa (Heavy Chain), under reducing conditions; 205.5 kDa, under non-reducing conditions. |
| 纯化方法 | Protein A purified |
| 物理外观 | Liquid |
| 储存缓冲液 | Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0 |
| 防腐剂 | No |
| 浓度 | 见COA |
| 储存温度 | -80℃储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| 稳定性与储存 | 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。 |
| CAS编号和信息 | 1450981-87-9 |
| 分子类型 | 抗体 |
Letolizumab (anti-TNFSF5) (Ab182769) - Flow
Flow Cytometry analysis of pLVX-puro-SYMX10-TNFSF5(CD40L)-FL-HEK293 cells labelling TNFSF5 with Letolizumab (anti-TNFSF5) (Ab182769), and negative control protein respectively, washed and then followed by PE and analyzed with the FACS EC
₅₀
is 0.05 nM.
Letolizumab (anti-TNFSF5) (Ab182769) - ELISA
Immobilized Recombinant Human CD40 Ligand protein (rp169583) at 1.0 μg/mL can bind Letolizumab (anti-TNFSF5) (Ab182769) with the EC
₅₀
of 11.26 ng/mL.
Letolizumab (anti-TNFSF5) (Ab182769) - SEC
The purity of Letolizumab (anti-TNFSF5) (Ab182769) is more than 95% verified by HPLC.
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
¥669.90
¥579.90
¥669.90
¥239.90
¥719.90
首页
400-620-6333
